| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO and Chairman
1 company
Bronson Crouch last filed a Form 4 in April 2025, as CEO and Chairman at TIL. Bronson Crouch's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 37,980,073 shares of TIL. Net of sales, the TIL filings show accumulation of 450,000 shares.
Bronson Crouch has 8 Form 4 filings on record from March 2021 to April 2025, all as CEO and Chairman at Instil Bio (TIL), 2021–2025.
The 11 reported transactions were 7 option or other derivative awards, 3 conversions and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $9.0M and no sales.
The only open-market purchase was 450,000 shares of TIL at an average $20.00 on March 23, 2021, about $9.0M. Twelve months later TIL was down 59%.
Shares as reported in the last Form 4 for each company; the most recent is from April 2025. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 23, 2021 | TIL Instil Bio, Inc. | CEO and Chairman | Buy | 450,000 | $20.00 | $9,000,000.00 | +1.2% | -28.9% | -58.7% |